BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 27431904)

  • 1. Cross-sectional study of Pfizer-sponsored clinical trials: assessment of time to publication and publication history.
    Mooney LA; Fay L
    BMJ Open; 2016 Jul; 6(7):e012362. PubMed ID: 27431904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of study outcome on submission and acceptance metrics for peer reviewed medical journals: six year retrospective review of all completed GlaxoSmithKline human drug research studies.
    Evoniuk G; Mansi B; DeCastro B; Sykes J
    BMJ; 2017 Apr; 357():j1726. PubMed ID: 28432051
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of editorial and peer review processes in publication bias: analysis of drug trials submitted to eight medical journals.
    van Lent M; Overbeke J; Out HJ
    PLoS One; 2014; 9(8):e104846. PubMed ID: 25118182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis.
    Ross JS; Tse T; Zarin DA; Xu H; Zhou L; Krumholz HM
    BMJ; 2012 Jan; 344():d7292. PubMed ID: 22214755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-publication and delayed publication of randomized trials on vaccines: survey.
    Manzoli L; Flacco ME; D'Addario M; Capasso L; De Vito C; Marzuillo C; Villari P; Ioannidis JP
    BMJ; 2014 May; 348():g3058. PubMed ID: 24838102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
    Ohnmeiss DD
    Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Authors' Submission Toolkit: a practical guide to getting your research published.
    Chipperfield L; Citrome L; Clark J; David FS; Enck R; Evangelista M; Gonzalez J; Groves T; Magrann J; Mansi B; Miller C; Mooney LA; Murphy A; Shelton J; Walson PD; Weigel A
    Curr Med Res Opin; 2010 Aug; 26(8):1967-82. PubMed ID: 20569069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between information in registries and articles did not influence publication acceptance.
    van Lent M; IntHout J; Out HJ
    J Clin Epidemiol; 2015 Sep; 68(9):1059-67. PubMed ID: 25542517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delays in reporting and publishing trial results during pandemics: cross sectional analysis of 2009 H1N1, 2014 Ebola, and 2016 Zika clinical trials.
    Jones CW; Adams AC; Murphy E; King RP; Saracco B; Stesis KR; Cavanaugh S; Roberts BW; Platts-Mills TF
    BMC Med Res Methodol; 2021 Jun; 21(1):120. PubMed ID: 34103009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors impacting time to acceptance and publication for peer-reviewed publications.
    Toroser D; Carlson J; Robinson M; Gegner J; Girard V; Smette L; Nilsen J; O'Kelly J
    Curr Med Res Opin; 2017 Jul; 33(7):1183-1189. PubMed ID: 27977312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noncompletion and nonpublication of trials studying rare diseases: A cross-sectional analysis.
    Rees CA; Pica N; Monuteaux MC; Bourgeois FT
    PLoS Med; 2019 Nov; 16(11):e1002966. PubMed ID: 31751330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Publication of sports medicine-related randomized controlled trials registered in ClinicalTrials.gov.
    Chahal J; Tomescu SS; Ravi B; Bach BR; Ogilvie-Harris D; Mohamed NN; Gandhi R
    Am J Sports Med; 2012 Sep; 40(9):1970-7. PubMed ID: 22679295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Processes to manage analyses and publications in a phase III multicenter randomized clinical trial.
    Snow KK; Bell MC; Stoddard AM; Curto TM; Wright EC; Dienstag JL
    Trials; 2014 May; 15():159. PubMed ID: 24886378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis.
    Ross JS; Mulvey GK; Hines EM; Nissen SE; Krumholz HM
    PLoS Med; 2009 Sep; 6(9):e1000144. PubMed ID: 19901971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peer review is an effective screening process to evaluate medical manuscripts.
    Abby M; Massey MD; Galandiuk S; Polk HC
    JAMA; 1994 Jul; 272(2):105-7. PubMed ID: 8015116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discontinuation and non-publication of surgical randomised controlled trials: observational study.
    Chapman SJ; Shelton B; Mahmood H; Fitzgerald JE; Harrison EM; Bhangu A
    BMJ; 2014 Dec; 349():g6870. PubMed ID: 25491195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peer review comments on drug trials submitted to medical journals differ depending on sponsorship, results and acceptance: a retrospective cohort study.
    van Lent M; IntHout J; Out HJ
    BMJ Open; 2015 Sep; 5(9):e007961. PubMed ID: 26423849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acceptance rates for manuscripts submitted to veterinary peer-reviewed journals in 2012.
    Lamb CR; Adams CA
    Equine Vet J; 2015 Nov; 47(6):736-40. PubMed ID: 25302854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unpublished completed obstetric randomized clinical trials registered at ClinicalTrials.gov: how big is this issue?
    Gupta M; Oliver EA; Chauhan SP; Wagner SM; Mol B; Berghella V
    Am J Obstet Gynecol MFM; 2023 Sep; 5(9):101066. PubMed ID: 37419451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scientific sinkhole: The pernicious price of formatting.
    LeBlanc AG; Barnes JD; Saunders TJ; Tremblay MS; Chaput JP
    PLoS One; 2019; 14(9):e0223116. PubMed ID: 31557272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.